Literature DB >> 1574181

Epilepsy, antiepileptic drugs, and malformations in children of women with epilepsy: a French prospective cohort study.

C Dravet1, C Julian, C Legras, A Magaudda, R Guerrini, P Genton, S Soulayrol, N Giraud, E Mesdjian, G Trentin.   

Abstract

We conducted a prospective study of teratogenic effects of antiepileptic drugs (AEDs) in pregnant women with epilepsy in southeast France, comparing malformation rates with those collected by a birth defects registry. We evaluated isolated microcephalies separately. Malformations were seen in 7% of infants of mothers with epilepsy (IME) and in 1.36% of the general population. No significant relationship was found between type and severity of epilepsy and occurrence of malformations or isolated microcephaly. Valproate and phenytoin were the most teratogenic (all malformations). None of the malformations observed in IME whose mothers received valproate, phenytoin, or phenobarbital was seen in IME not exposed to the respective AEDs. Phenytoin plus phenobarbital was more teratogenic than phenobarbital alone. Benzodiazepines, prescribed only in combinations, had a borderline, nonspecific effect on microcephaly.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1574181

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  13 in total

1.  Using current evidence in selecting antiepileptic drugs for use during pregnancy.

Authors:  Page B Pennell
Journal:  Epilepsy Curr       Date:  2005 Mar-Apr       Impact factor: 7.500

2.  The effects of a history of seizures during pregnancy on umbilical arterial blood gas values in pregnant women with epilepsy.

Authors:  Ozhan Ozdemir; Mustafa Erkan Sarı; Funda Arpacı Ertuğrul; Aslıhan Kurt; Vefa Selimova; Cemal Reşat Atalay
Journal:  J Turk Ger Gynecol Assoc       Date:  2014-08-08

Review 3.  Assessing the safety of drugs in pregnancy: the role of prospective cohort studies.

Authors:  C Irl; J Hasford
Journal:  Drug Saf       Date:  2000-03       Impact factor: 5.606

4.  Maternal bronchodilator use and the risk of orofacial clefts.

Authors:  JeanPierre W Munsie; Shao Lin; Marilyn L Browne; Kimberly A Campbell; Alissa R Caton; Erin M Bell; Sonja A Rasmussen; Paul A Romitti; Charlotte M Druschel
Journal:  Hum Reprod       Date:  2011-09-15       Impact factor: 6.918

Review 5.  Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child.

Authors:  Jennifer Weston; Rebecca Bromley; Cerian F Jackson; Naghme Adab; Jill Clayton-Smith; Janette Greenhalgh; Juliet Hounsome; Andrew J McKay; Catrin Tudur Smith; Anthony G Marson
Journal:  Cochrane Database Syst Rev       Date:  2016-11-07

Review 6.  Management of epilepsy in women of childbearing age: practical recommendations.

Authors:  Barbara Tettenborn
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

Review 7.  Pregnancy outcomes in women with epilepsy: a systematic review and meta-analysis of published pregnancy registries and cohorts.

Authors:  Kimford Meador; Matthew W Reynolds; Sheila Crean; Kyle Fahrbach; Corey Probst
Journal:  Epilepsy Res       Date:  2008-06-18       Impact factor: 3.045

Review 8.  Antiepileptic drugs during pregnancy: what is known and which AEDs seem to be safest?

Authors:  Page B Pennell
Journal:  Epilepsia       Date:  2008-12       Impact factor: 5.864

Review 9.  Management of epilepsy during pregnancy.

Authors:  Dina Battino; Torbjörn Tomson
Journal:  Drugs       Date:  2007       Impact factor: 9.546

10.  Pregnancy outcome after in utero exposure to valproate : evidence of dose relationship in teratogenic effect.

Authors:  Orna Diav-Citrin; Svetlana Shechtman; Benjamin Bar-Oz; Dana Cantrell; Judy Arnon; Asher Ornoy
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.